Thomas Richard Kassberg, CBO & EVP at Ultragenyx Pharmaceutical Inc. (RARE), sold 20,562 shares at $67.01 ($1.4M) on 2022-03-11, disclosed to the SEC on 2022-03-15.
Seasonal sale ($1.4M) by CBO & EVP — this insider has traded RARE in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $67.01 | 10,281 | $689K | 50.0% |
| 2 | $67.01 | 10,281 | $689K | 50.0% |
| Total | $67.01 avg | 20,562 | $1.4M | 100% |
| Filing → |
| RARE | SELL | 2024-03-05 | $109K | — | Filing → |
| RARE | SELL | 2023-10-24 | $2.6M | — | Filing → |
| RARE | SELL | 2023-03-03 | $178K | — | Filing → |